Google
 
Google

World Stem Cell Summit 2010

Tuesday, March 18, 2008

British Journal of Cancer - Table of Contents alert Volume 98 Issue 6

Sponsored By ABCAM

Providing cutting edge antibodies to researchers worldwide

Abcam's catalog http://ealerts.nature.com/cgi-bin24/DM/y/ejj30Xztnp0Hhi0BnuL0Eq
of over 40,000 reagents includes research tools for immunology,
cancer,neuroscience, chromatin, stem cells, cardiovascular
and nuclear signaling.Browse Abcam's immunology range of over
8,800 products,read customer product reviews and
visit the immunology resource centre at
http://ealerts.nature.com/cgi-bin24/DM/y/ejj30Xztnp0Hhi0BnuM0Er .


British Journal of Cancer
18 March 2008, Volume 98, Issue 6
Table of Contents

Editorial

1021 Further evidence of clinical benefit associated with
participation in phase I oncology trials

M Markman

http://ealerts.nature.com/cgi-bin24/DM/y/ejj30Xztnp0Hhi0BqLW0EP
_____________________________________________________________________

Review

1023 Approaches to working in high-dimensional data spaces: gene
expression microarrays

Y Wang, D J Miller and R Clarke

http://ealerts.nature.com/cgi-bin24/DM/y/ejj30Xztnp0Hhi0BqLX0EQ
_____________________________________________________________________

Clinical Studies

1029 Clinical outcome and prognostic factors for patients treated
within the context of a phase I study: the Royal Marsden
Hospital experience

H-T Arkenau, D Olmos, J E Ang, J de Bono, I Judson and S
Kaye

http://ealerts.nature.com/cgi-bin24/DM/y/ejj30Xztnp0Hhi0BqLY0ER
_____________________________________________________________________

1034 Phase I/II study of oxaliplatin with oral S-1 as first-line
therapy for patients with metastatic colorectal cancer

Y Yamada, M Tahara, T Miya, T Satoh, K Shirao, Y Shimada,
A Ohtsu, Y Sasaki and Y Tanigawara

http://ealerts.nature.com/cgi-bin24/DM/y/ejj30Xztnp0Hhi0BqLZ0ES
_____________________________________________________________________

1039 Intra-arterial chemoradiotherapy for locally advanced oral
cavity cancer: analysis of therapeutic results in134 cases

N Fuwa, T Kodaira, K Furutani, H Tachibana, T Nakamura, R
Nakahara, T Tomoda, H Inokuchi and T Daimon

http://ealerts.nature.com/cgi-bin24/DM/y/ejj30Xztnp0Hhi0BqLa0EZ
_____________________________________________________________________

1046 Haemato-oncology and burnout: an Italian survey

C Bressi, S Manenti, M Porcellana, D Cevales, L Farina, I
Felicioni, G Meloni, G Milone, I R Miccolis, M Pavanetto,
L Pescador, M Poddigue, L Scotti, A Zambon, G Corrao, G
Lambertenghi-Deliliers and G Invernizzi

http://ealerts.nature.com/cgi-bin24/DM/y/ejj30Xztnp0Hhi0BqLb0Ea
_____________________________________________________________________

1053 Assessment of the efficacy and toxicity of
131I-metaiodobenzylguanidine therapy for metastatic
neuroendocrine tumours

A C Nwosu, L Jones, J Vora, G J Poston, S Vinjamuri and D
M Pritchard

http://ealerts.nature.com/cgi-bin24/DM/y/ejj30Xztnp0Hhi0BqLc0Eb
_____________________________________________________________________

Translational Therapeutics


1059 Erythropoietin receptor transcription is neither elevated nor
predictive of surface expression in human tumour cells

A M Sinclair, N Rogers, L Busse, I Archibeque, W Brown, P
D Kassner, J E V Watson, G E Arnold, K C Q Nguyen, S
Powers and S Elliott

http://ealerts.nature.com/cgi-bin24/DM/y/ejj30Xztnp0Hhi0BqLd0Ec
_____________________________________________________________________

1068 The involvement of FOXO1 in cytotoxic stress and
drug-resistance induced by paclitaxel in ovarian cancers

T Goto, M Takano, J Hirata and H Tsuda

http://ealerts.nature.com/cgi-bin24/DM/y/ejj30Xztnp0Hhi0BqLe0Ed
_____________________________________________________________________

1076 Activity of lapatinib a novel HER2 and EGFR dual kinase
inhibitor in human endometrial cancer cells

G E Konecny, N Venkatesan, G Yang, J Dering, C Ginther, R
Finn, M Rahmeh, M Schoenberg Fejzo, D Toft, S-W Jiang, D J
Slamon and K C Podratz

http://ealerts.nature.com/cgi-bin24/DM/y/ejj30Xztnp0Hhi0BqLf0Ee
_____________________________________________________________________

Molecular Diagnostics

1085 The E3 ubiquitin ligase EDD is an adverse prognostic factor for
serous epithelial ovarian cancer and modulates cisplatin
resistance in vitro

P M O'Brien, M J Davies, J P Scurry, A N Smith, C A
Barton, M J Henderson, D N Saunders, B S Gloss, K I
Patterson, J L Clancy, V A Heinzelmann-Schwarz, R A
Scolyer, Y Zeng, E D Williams, L Scurr, A DeFazio, D I
Quinn, C K W Watts, N F Hacker, S M Henshall and R L
Sutherland

http://ealerts.nature.com/cgi-bin24/DM/y/ejj30Xztnp0Hhi0BqLg0Ef
_____________________________________________________________________

1094 Phosphorylation of the androgen receptor is associated with
reduced survival in hormone-refractory prostate cancer
patients

P McCall, L K Gemmell, R Mukherjee, J M S Bartlett and J
Edwards

http://ealerts.nature.com/cgi-bin24/DM/y/ejj30Xztnp0Hhi0BqLh0Eg
_____________________________________________________________________

1102 Met expression is an independent prognostic risk factor in
patients with oesophageal adenocarcinoma

J B Tuynman, S M Lagarde, F J W ten Kate, D J Richel and J
J B van Lanschot

http://ealerts.nature.com/cgi-bin24/DM/y/ejj30Xztnp0Hhi0BqLi0Eh
_____________________________________________________________________

1109 The clinical significance of splice variants and subcellular
localisation of survivin in non-small cell lung cancers

J Nakano, C Huang, D Liu, D Masuya, H Yokomise, M Ueno, R
Haba and S Sumitomo

http://ealerts.nature.com/cgi-bin24/DM/y/ejj30Xztnp0Hhi0BqLj0Ei
_____________________________________________________________________

Genetics and Genomics

1118 High tumour islet macrophage infiltration correlates with
improved patient survival but not with EGFR mutations,
gene copy number or protein expression in resected
non-small cell lung cancer

D-W Kim, H S Min, K-H Lee, Y J Kim, D-Y Oh, Y K Jeon, S-H
Lee, S-A Im, D H Chung, Y T Kim, T-Y Kim, Y-J Bang, S W
Sung, J H Kim and D S Heo

http://ealerts.nature.com/cgi-bin24/DM/y/ejj30Xztnp0Hhi0BqLk0Ej
_____________________________________________________________________

1125 HLA-associated susceptibility to childhood B-cell precursor
ALL: definition and role of HLA-DPB1 supertypes

G M Taylor, A Hussain, T J Lightfoot, J M Birch, T O B
Eden and M F Greaves

http://ealerts.nature.com/cgi-bin24/DM/y/ejj30Xztnp0Hhi0BqLl0Ek
_____________________________________________________________________

1132 Phosphorylation of the ErbB3 binding protein Ebp1 by
p21-activated kinase 1 in breast cancer cells

D Akinmade, A H Talukder, Y Zhang, W-m Luo, R Kumar and A
W Hamburger

http://ealerts.nature.com/cgi-bin24/DM/y/ejj30Xztnp0Hhi0BqLm0El
_____________________________________________________________________

1141 Growth arrest-specific gene 6 expression in human breast cancer

O Mc Cormack, W Y Chung, P Fitzpatrick, F Cooke, B Flynn,
M Harrison, E Fox, E Gallagher, A Mc Goldrick, P A Dervan,
A Mc Cann and M J Kerin

http://ealerts.nature.com/cgi-bin24/DM/y/ejj30Xztnp0Hhi0BqLn0Em
_____________________________________________________________________

1147 Frequent epigenetic inactivation of Wnt antagonist genes in
breast cancer

H Suzuki, M Toyota, H Caraway, E Gabrielson, T Ohmura, T
Fujikane, N Nishikawa, Y Sogabe, M Nojima, T Sonoda, M
Mori, K Hirata, K Imai, Y Shinomura, S B Baylin and T
Tokino

http://ealerts.nature.com/cgi-bin24/DM/y/ejj30Xztnp0Hhi0BqLo0En
_____________________________________________________________________


======================================================================

You have been sent this Table of Contents Alert because you have opted in to receive it.
You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at:
http://www.nature.com/myaccount
(You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department:
registration@nature.com

For print subscription enquiries, please contact our subscription department:
subscriptions@nature.com

For other enquiries, please contact customer feedback department:
feedback@nature.com

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne -
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and
Wales under company number 785998 and whose registered office is located
at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

(c) Copyright 2008 Nature Publishing Group

======================================================================

Google

Any Comments ?.......

E-mail: manojhind2001us@gmail.com
Google
 

World Time